Global Transurethral Prostatic Resection Device Market Growth (Status and Outlook) 2023-2029

Global Transurethral Prostatic Resection Device Market Growth (Status and Outlook) 2023-2029

The global Transurethral Prostatic Resection Device market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Transurethral Prostatic Resection Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Transurethral Prostatic Resection Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Transurethral Prostatic Resection Device is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Transurethral Prostatic Resection Device players cover Wellspect HealthCare, Manfred Sauer, Teleflex, Hollister, Boston Scientific, Karl Storz, Olympus, Lumenis and Covidien, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

A transurethral resection of the prostate (TURP) is a surgical procedure that involves cutting away a section of the prostate. The prostate is a small gland in the pelvis only found in men. It's located between the penis and bladder, and surrounds the urethra (the tube that carries urine from the bladder to the penis).

LPI (LP Information)' newest research report, the “Transurethral Prostatic Resection Device Industry Forecast” looks at past sales and reviews total world Transurethral Prostatic Resection Device sales in 2022, providing a comprehensive analysis by region and market sector of projected Transurethral Prostatic Resection Device sales for 2023 through 2029. With Transurethral Prostatic Resection Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transurethral Prostatic Resection Device industry.

This Insight Report provides a comprehensive analysis of the global Transurethral Prostatic Resection Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Transurethral Prostatic Resection Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Transurethral Prostatic Resection Device market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transurethral Prostatic Resection Device and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transurethral Prostatic Resection Device.

This report presents a comprehensive overview, market shares, and growth opportunities of Transurethral Prostatic Resection Device market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Monopolar TURP
Bipolar TURP

Segmentation by application
Benign Prostate Hyperplasia
Urinary Tract Infection
Erectile Dysfunction
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Wellspect HealthCare
Manfred Sauer
Teleflex
Hollister
Boston Scientific
Karl Storz
Olympus
Lumenis
Covidien
Cook Medical

Please note: The report will take approximately 2 business days to prepare and deliver.